Systematic Review

Published on 13 Jan 2023

Platelet–lymphocyte ratio is a prognostic marker in small cell lung cancer—A systemic review and meta-analysis

in Thoracic Oncology

Hongbin Zhou
Jiuke Li
Yiting Zhang
Zhewen Chen
Ying Chen
Sa Ye

Frontiers in Oncology

doi 10.3389/fonc.2022.1086742

1,571 views
7 citations

Case Report

Published on 13 Jan 2023

Case report: Identification of acute promyelocytic leukemia during osimertinib resistance followed by granulocyte colony-stimulating factor and pembrolizumab

in Thoracic Oncology

Huohuan Tian
Linhui Yang
Wang Hou
Yu Wu
Yang Dai
Jiang Yu
Dan Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1032225

2,118 views
1 citation

Original Research

Published on 12 Jan 2023

Efficacy and safety evaluation of neoadjuvant immunotherapy plus chemotherapy for resectable non–small cell lung cancer in real world

in Thoracic Oncology

Min Fang
Qingqing Hang
Haitao Jiang
Lei Cai
Jinlin Hu
Hangjie Ying
Qing Gu
Xiaofu Yu
Jinshi Liu
Xiaojing Lai

Frontiers in Oncology

doi 10.3389/fonc.2022.1055610

2,524 views
6 citations

Original Research

Published on 10 Jan 2023

The role of surgery in advanced thymic tumors: A retrospective cohort study

in Thoracic Oncology

Weifeng Qi
Hui Tian

Frontiers in Oncology

doi 10.3389/fonc.2022.1073641

1,545 views
2 citations

Original Research

Published on 09 Jan 2023

Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study

in Thoracic Oncology

Zhiting Zhao
Luqing Zhao
Guohao Xia
Jianwei Lu
Bo Shen
Guoren Zhou
Fenglei Wu
Xiao Hu
Jifeng Feng
Shaorong Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.1036906

2,631 views
5 citations

Case Report

Published on 09 Jan 2023

Successful treatment of a patient with advanced lung adenocarcinoma (EGFR-T790M and C797S cis) with lazertinib: A case report and literature review

in Thoracic Oncology

Yue Fang
Qiankun Zhang
Weimin Wang
Juanjuan Tong
Xialin Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1037964

1,879 views
1 citation

Original Research

Published on 09 Jan 2023

Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma

in Thoracic Oncology

Yuki Katsuya
Shigehisa Kitano
Makiko Yamashita
Mayu Ouchi
Shigehiro Yagishita
Akinobu Hamada
Hiromi Nakamura
Fumie Hosoda
Tatsuhiro Shibata
Noriko Motoi

Frontiers in Oncology

doi 10.3389/fonc.2022.966527

2,339 views

Case Report

Published on 06 Jan 2023

Case report: Imaging findings of true thymic hyperplasia at 18F-FDG PET/CT in an infant

in Thoracic Oncology

Jiazhong Ren
Zheng Fu
Yaqing Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.1077777

1,588 views

Original Research

Published on 05 Jan 2023

Upregulation of complement proteins in lung cancer cells mediates tumor progression

in Thoracic Oncology

Emily K. Kleczko
Joanna M. Poczobutt
Andre C. Navarro
Jennifer Laskowski
Amber M. Johnson
Sean P. Korpela
Natalia J. Gurule
Lynn E. Heasley
Katharina Hopp
Mary C.M. Weiser-Evans

Frontiers in Oncology

doi 10.3389/fonc.2022.1045690

3,318 views
4 citations

Original Research

Published on 04 Jan 2023

Prognostic relevance of rib invasion and modification of T description for resected NSCLC patients: A propensity score matching analysis of the SEER database

in Thoracic Oncology

Yiyong Chen
Juan Zhang
Jing Chen
Zijie Yang
Yun Ding
Wenshu Chen
Tianxing Guo
Lilan Zhao
Xiaojie Pan

Frontiers in Oncology

doi 10.3389/fonc.2022.1082850

1,519 views
3 citations

Review

Published on 04 Jan 2023

Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region

in Thoracic Oncology

Milan J. Anadkat
Mario Lacouture
Adam Friedman
Zachary D. Horne
Jae Jung
Benjamin Kaffenberger
Sujith Kalmadi
Liza Ovington
Rupesh Kotecha
Huda Ismail Abdullah

Frontiers in Oncology

doi 10.3389/fonc.2022.975473

7,333 views
10 citations

Original Research

Published on 23 Dec 2022

Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma

in Thoracic Oncology

Wei Liu
Qian Zhang
Tiantian Zhang
Li Li
Chunhua Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.1090544

1,716 views
2 citations

Case Report

Published on 23 Dec 2022

Successful treatment of extensive-stage small cell lung cancer with concurrent pleural and pericardial effusions: Case report

in Thoracic Oncology

Ayaka Kashima
Yosuke Fukuda
Miri Shimamura
Miharu Ijichi
Hironori Sagara

Frontiers in Oncology

doi 10.3389/fonc.2022.1040452

1,830 views
2 citations

Original Research

Published on 22 Dec 2022

Identifying diagnostic markers and constructing a prognostic model for small-cell lung cancer based on blood exosome-related genes and machine-learning methods

in Thoracic Oncology

Kun Zhang
Chaoguo Zhang
Ke Wang
Xiuli Teng
Mingwei Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1077118

2,980 views
2 citations

Case Report

Published on 22 Dec 2022

Case report: Rare intrapulmonary malignant mesothelioma complicated with myositis

in Thoracic Oncology

Dandan Gong
Jian Yu
Xiaodong Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.1074821

1,436 views
1 citation

Original Research

Published on 22 Dec 2022

Knowledge mapping visualization of the pulmonary ground-glass opacity published in the web of science

in Thoracic Oncology

Xingchen Li
Guochao Zhang
Shugeng Gao
Qi Xue
Jie He

Frontiers in Oncology

doi 10.3389/fonc.2022.1075350

1,983 views

Navigation group

Articles

Platelet–lymphocyte ratio is a prognostic marker in small cell lung cancer—A systemic review and meta-analysis

Case report: Identification of acute promyelocytic leukemia during osimertinib resistance followed by granulocyte colony-stimulating factor and pembrolizumab

Efficacy and safety evaluation of neoadjuvant immunotherapy plus chemotherapy for resectable non–small cell lung cancer in real world

The role of surgery in advanced thymic tumors: A retrospective cohort study

Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study

Successful treatment of a patient with advanced lung adenocarcinoma (EGFR-T790M and C797S cis) with lazertinib: A case report and literature review

Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma

Case report: Imaging findings of true thymic hyperplasia at 18F-FDG PET/CT in an infant

Upregulation of complement proteins in lung cancer cells mediates tumor progression

Prognostic relevance of rib invasion and modification of T description for resected NSCLC patients: A propensity score matching analysis of the SEER database

Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region

Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma

Successful treatment of extensive-stage small cell lung cancer with concurrent pleural and pericardial effusions: Case report

Identifying diagnostic markers and constructing a prognostic model for small-cell lung cancer based on blood exosome-related genes and machine-learning methods

Case report: Rare intrapulmonary malignant mesothelioma complicated with myositis

Knowledge mapping visualization of the pulmonary ground-glass opacity published in the web of science